Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Funding for research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) across the lifespan with the aim of reducing prenatal alcohol exposure and advancing intervention methods.
Funder: National Institutes of Health
Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision) | October 16, 2026 (New) | November 16, 2026 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 direct costs in any single year.
Summary: Supports pilot and feasibility research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) across the lifespan, aiming to reduce prenatal alcohol exposure and improve outcomes for affected individuals.
Key Information: Animal studies and HIV/AIDS-related research are not responsive; foreign organizations are eligible; clinical trial optional.
Description
This opportunity supports R34 planning grants for research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) throughout the lifespan. The goal is to advance approaches that reduce prenatal alcohol exposure and the incidence of FASD, as well as to develop and test interventions for individuals affected by FASD. Projects should generate pilot or feasibility data to inform future, larger-scale studies (e.g., R01).
Research may include, but is not limited to:
- Novel prevention or intervention strategies based on basic science findings.
- Theory-based interventions needing further evaluation.
- Approaches to enhance effectiveness, reach, or scalability of interventions in community or clinical settings.
- Strategies to improve implementation or evaluation of effective interventions.
- Development and testing of multicomponent interventions.
Applications may address prevention in high-risk or underserved populations, development of culturally sensitive interventions, strategies to reduce stigma, or innovative methods to improve identification and care for individuals with FASD.
Note: Applications focused on animal studies or HIV/AIDS-related research will not be considered responsive.
